| Literature DB >> 25550728 |
Abstract
Galactans ranging in length from one to five residues were prepared in a single step by treatment of the glycosyl donor 2,3,4-tri-O-benzoyl-β-D-galactopyranosyl fluoride with lanthanum perchlorate in the presence of an initiator alcohol. The product oligosaccharides were readily chromatographically separable. This oligomerization was used to synthesize a pentagalactan in a single step from monosaccharide building blocks in reasonable overall yields.Entities:
Keywords: arabinogalactan protein; glycosyl fluoride; glycosylation; oligosaccharides
Year: 2014 PMID: 25550728 PMCID: PMC4273286 DOI: 10.3762/bjoc.10.279
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Figure 1Pyrenebutanol (3) initiated oligomerization.
Optimization of oligomerization reaction conditions.
| Entry | Conditions | Overall | Cappingb | |||||
| 1 | 50 | 21 | 12 | – | – | 83 (39) | a | |
| 2 | – | – | – | – | – | N.R.c | a | |
| 3 | 99 | – | – | – | – | 99 (30) | – | |
| 4 | 55 | 29 | 11 | 3 | – | 98 (50) | b1 | |
| 5 | 50 | 29 | 9 | 4 | – | 92 (54) | b2 | |
| 6 | 40 | 19 | 4 | – | – | 63 (28) | b1 | |
| 7 | 58 | 29 | 10 | 3 | – | 100 (55) | b1 | |
| 8 | – | – | – | – | – | N.R | b1 | |
| 9 | 39 | 33 | 18 | 4 | – | 94 (54) | b1 | |
| 10 | 40 | 35 | 19 | 5 | – | 99 (40) | b1 | |
| 11 | 46 | 32 | 14 | 5 | 2 | 99 (60) | c | |
| 12 | 37 | 39 | 15 | 6 | 3 | 97 (60) | c | |
aThe first number treats the glycosyl acceptor as the limiting reagent, and is the sum of the individual yields of the mono-, di-, trisaccharide etc. The value inside parentheses corresponds to the % yield of the donor summed across all the products. The second value is the yield of the reaction when the glycosyl donor is treated as the limiting reagent, and takes into account the fact that the reaction stoichiometry with respect to the donor varies for each oligosaccharide when summing up the total yield. The difference between the standard acceptor yield and the (donor yield) provides a sense of how efficiently/inefficiently the donor is incorporated into one of the products. Additional details of the donor yields for each of the oliogosaccharide products and a sample calculation are provided in Supporting Information File 1. bCapping protocol for purification: a) Ac2O, pyridine; b1) TMSCl/HMDS; b2) TMSCN; c) TBSCl, imidazole. cN.R. – no reaction;
Figure 2Scope of oligomerization.
Oligomerizations with variations in initiating acceptors.
| Entry | Acceptor | Product | ( | ( | ( | ( | ( | Overall | Cappingb |
| 1 | 53 | 24 | 9 | 6 | – | 92 (49) | b2 | ||
| 2 | 77 | 17 | 6 | – | – | 99 (50) | c | ||
| 3 | – | 43 | 26 | 11 | – | 80 (40) | b1 | ||
| 4 | – | 50 | 21 | 8 | – | 79 (36) | b2 | ||
| 5 | – | 47 | 19 | 10 | 4 | 80 (44) | c | ||
| 6 | 77 | 22 | – | – | – | 98 (49) | c | ||
| 7 | 30 | 28 | – | – | – | 58 (27) | b1 | ||
| 8 | 33 | – | – | – | 33 (10) | b1 | |||
| 9 | – | – | 34 | 13 | 8 | 55 (27) | b1 | ||
aSee caption under Table 1. bCapping protocol for purification: b1) TMSCl/HMDS; b2) TMSCN; c) TBSCl, imidazole.